Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CG Oncology (CGON) Gross Margin (2024 - 2025)

CG Oncology's Gross Margin history spans 2 years, with the latest figure at 32.21% for Q4 2025.

  • For Q4 2025, Gross Margin fell 13221.0% year-over-year to 32.21%; the TTM value through Dec 2025 reached 3.96%, changed N/A, while the annual FY2025 figure was 15.02%, 11502.0% down from the prior year.
  • Gross Margin reached 32.21% in Q4 2025 per CGON's latest filing, down from 5.34% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 100.0% in Q3 2024 to a low of 32.21% in Q4 2025.